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ABSTRACT
The production of neurons from neural progenitor cells, the
growth of axons and dendrites and the formation and
reorganization of synapses are examples of neuroplasticity.
These processes are regulated by cell-autonomous and
intercellular (paracrine and endocrine) programs that
mediate responses of neural cells to environmental input.
Mitochondria are highly mobile and move within and
between subcellular compartments involved in neuroplas-
ticity (synaptic terminals, dendrites, cell body and the
axon). By generating energy (ATP and NAD
+), and
regulating subcellular Ca
2+ and redox homoeostasis,
mitochondria may play important roles in controlling
fundamental processes in neuroplasticity, including neural
differentiation, neurite outgrowth, neurotransmitter
release and dendritic remodelling. Particularly intriguing
is emerging data suggesting that mitochondria emit
molecular signals (e.g. reactive oxygen species, proteins
and lipid mediators) that can act locally or travel to distant
targets including the nucleus. Disturbances in mitochon-
drial functions and signalling may play roles in impaired
neuroplasticity and neuronal degeneration in Alzheimer’s
disease, Parkinson’s disease, psychiatric disorders and
stroke.
Key words: neural progenitor cell, mitochondria biogenesis,
mitochondria fission and fusion.
INTRODUCTION
Neuroplasticity is a term used to describe a range of adaptive
changes that occur in the structure and function of cells in
the nervous system in response to physiological or patho-
logical perturbations. Examples of neuroplasticity include the
sprouting and growth of axons or dendrites, synapse
formation, the strengthening of synapses in response to
repeated activation and neurogenesis (the production of new
neurons from stem cells). The biological basis of this capacity
for structural and functional adaptation encompasses a
diverse set of cellular and molecular mechanisms, including
the pre- and post-synaptic apparatuses for neurotransmis-
sion, cytoskeletal remodelling, membrane trafficking, gene
transcription, protein synthesis and proteolysis (Shepherd and
Huganir, 2007; Bramham, 2008; Greer and Greenberg, 2008;
Pak et al., 2008; Tai and Schuman, 2008; Shah et al., 2010). In
addition, glial cells (astrocytes, microglia and oligodendro-
cytes) play important roles in neuroplasticity by producing
soluble and surface-bound factors that influence neurite
outgrowth, synaptic plasticity and cell survival (Haydon and
Carmignoto, 2006; Barres, 2008).
Among the many specialized cell types in the body,
neurons are particularly marvellous because they elaborate
tree-like shapes, are electrically excitable, and engage in
spectacular spatiotemporal displays of signal detection,
integration and storage, and generation of adaptive res-
ponses to life situations. Newly generated neurons possess an
intrinsic pre-ordained sequence of events that determine at
least some of their structural and functional phenotypes. For
example, the dendritic morphology of cerebellar Purkinje cells
is largely established independently of interactions with other
cells (Sotelo and Dusart, 2009). Interestingly, the most closely
related neuronal cells, mitotic sister neurons arising from a
common progenitor, elaborate morphologies more similar to
themselves compared with their close neighbours (Mattson
et al., 1989). While the cytoarchitecture and functional
capabilities of the nervous system are highly complex, several
of the signalling mechanisms that control the formation and
adaptive plasticity have been elucidated. Neurotransmitters,
neurotrophic factors and cell adhesion molecules are three
highly conserved classes of intercellular signals that regulate
the genesis and adaptive plasticity of nervous systems
(Mattson, 1988; Loers and Schachner, 2007; Gottmann
et al., 2009). The most intensively studied representatives of
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asnneuro.org / Volume 2 (5) / art:e00045 243these three classes of signals are the excitatory neurotrans-
mitter glutamate (Mattson, 2008; Newpher and Ehlers, 2008),
BDNF (brain-derived neurotrophic factor; Mattson et al.,
2004; Lipsky and Marini, 2007) and the NCAM (neural cell
adhesion molecule; Hildebrandt et al., 2007). Details of the
components of these signalling pathways will not be covered
in the present paper. Instead, we focus on emerging findings
regarding the interactions of the latter signalling pathways
with mitochondria, an organelle increasingly recognized as
not only a power station, but also as a signalling platform
involved in fundamental events in the formation and
plasticity of neuronal circuits.
Mitochondria are vital ATP-generating organelles present
in all eukaryotic cells. In addition to converting energy
substrates into ATP, mitochondria participate in ROS (reactive
oxygen species) metabolism, calcium signalling and apoptosis
(Mattson et al., 2008). Mitochondria are distributed through-
out the length of axons and in presynaptic terminals.
Mitochondria in dendrites are located mainly in the dendritic
shafts and are occasionally found associated with spines
(Cameron et al., 1991; Popov et al., 2005).
The application of novel imaging and molecular biology
technologies to studies of mitochondria has revealed several
surprising properties and functions of mitochondria in
neuroplasticity. For example, we now know that mitochondria
(i) move rapidly within and between subcellular compart-
ments (e.g. dendrites, the axon shaft, presynaptic terminals)
(Zinsmaier et al., 2009); (ii) undergo fission and fusion (Liesa
et al., 2009); (iii) respond (e.g. move, change their energy
output, take up or release calcium) to electrical activity and
activation of neurotransmitter and growth factor receptors
(Macaskill et al., 2009); and (iv) function as signalling
outposts that contain kinases, deacetylases and other signal
transduction enzymes (Stowe and Camara, 2009).
Mitochondrial fission and fusion are mediated by two distinct
protein complexes involving GTPase. Key molecular mechan-
isms involved in mitochondrial fission and fusion have
recently been elucidated (Berman et al., 2008). Two key
proteins, Drp (dynamin-related protein) and Fis1, mediate
mitochondrial fission, whereas mitofusins (Mfn1 and Mfn2)
and OPA1 (Optic Atrophy-1) mediate mitochondrial fusion
(Karbowski et al., 2002; Shaw and Nunnari, 2002; Koshiba
et al., 2004; Detmer and Chan, 2007). Mitochondrial fission
and fusion can occur rapidly (within less than 1 min) and
remodel individual mitochondria continuously. Mitochondria
dynamics are important for neuronal functions since they
regulate mitochondrial location, morphology, number and
function (Detmer and Chan, 2007).
The notion that mitochondria participate in neuroplasticity
is not new. For example, more than four decades ago, Sotelo
and Palay (1968) examined electron micrographs of the
lateral vestibular nucleus and observed: ‘‘The distal segments
of some dendrites display broad expansions packed with
slender mitochondria and glycogen particles. These distinctive
formations are interpreted as being growing tips of dendrites,
and the suggestion is advanced that they are manifestations
of architectonic plasticity in the mature central nervous
system.’’ In the present review article, we consider the
emerging roles of mitochondria in neuroplasticity.
Mitochondria and neurogenesis
Neurogenesis, the birth of new neurons from stem cells,
occurs rapidly and globally during development of the
nervous system, and to a much more limited extent in some
regions of the adult nervous system. Adult neurogenesis is
believed to be functionally important as a mechanism of
brain plasticity under physiological conditions and in brain
repair after injury (Kempermann et al., 2004; Ge et al., 2008;
Kitamura et al., 2009). How are mitochondria involved in
the process of neurogenesis? First, the mitochondria may play
a role in the self-renewal capacity of neural stem cells, a
defining property of all stem cells. Studies of mouse ES
(embryonic stem) cells suggest that the proliferative capacity
of stem cells is correlated with low mitochondrial oxygen
consumption and high levels of glycolytic activity (Kondoh
et al., 2007). Using typical bicarbonate buffer and a 5% CO2/
95% air atmosphere, cells are exposed to much higher levels
oxygen compared with what they would be exposed to
in vivo. Reducing the oxygen level enhances the proliferation
and multipotency of neural stem cells (Rodrigues et al., 2010;
Santilli et al., 2010). Human ES cells exhibit an ‘anaerobic’
metabolic profile, and when somatic cells are induced to
revert to an ES cell-like phenotype, their mitochondria
also revert to an ES cell-like state with respect to their
morphology, subcellular distribution, biogenesis, and ROS and
ATP production (Prigione et al., 2010). Cultured neural crest
stem cells incubated in the presence of bone morphogenetic
protein 2 and forskolin can be coaxed, by exposure to mild
hypoxia, to differentiate into a relatively pure population of
sympathoadrenal neuronal cells that produce adrenaline
(norepinephrine) and dopamine (Morrison et al., 2000). A
link between mitochondrial Ca handling and neurogenesis is
suggested by results showing that, when neuroblastoma cells
are induced to stop dividing and differentiate into neuron-
like cells, there is an increase of mitochondrial fusion and an
increase in intramitochondrial Ca
2+ levels (Voccoli and
Colombaioni, 2009).
The second step in neurogenesis is the differentiation of
neural progenitors into postmitotic neurons. While much has
been learned regarding the molecular changes involved in
neuronal differentiation (Hamby et al., 2008; Zhang et al.,
2008; Cane and Anderson, 2009), very little is known of the
roles of mitochondria in these processes. Neuronal differ-
entiation is associated with an increase in mitochondrial mass
per cell, and the mitochondrial translation inhibitor chlor-
amphenicol prevents differentiation, indicating participation
of the mitochondrial genome and mitochondrial protein
synthesis in neuronal differentiation (Vayssie `re et al., 1992).
The increased mitochondrial biogenesis associated with
differentiation provides ATP to support fundamental cellular
processes involved in neurite outgrowth (cytoskeletal
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and protein cargos).
While mitochondrial mass increases on neuronal differ-
entiation to increase ATP production (Figure 1), energy
generation is only one mechanism by which mitochondria
enable neurite outgrowth. Mitochondrial UCPs (uncoupling
proteins) have received increasing attention regarding their
roles in physiological processes other than heat generation in
brown fat cells (Mattson and Liu, 2003). By leaking protons
across the mitochondrial inner membrane, UCPs not only
reduce ATP production, but also decrease the generation of
ROS and modify mitochondrial and endoplasmic reticulum
Ca
2+ dynamics (Chan et al., 2006; Liu et al., 2006). UCP4 is
expressed preferentially in neurons (Liu et al., 2006) and its
developmental expression characteristics suggest a role for
UCP4 in neuronal differentiation (Smorodchenko et al., 2009).
In addition, the transcription factor NeuroD6 can induce the
differentiation of the neuronal progenitor-like PC12 cells and
up-regulate the expression of several mitochondria-related
genes; NeuroD6-induced expression of mitochondrial genes is
maximum at a very early stage of neurite outgrowth (Baxter
et al., 2009). One mitochondria-related gene induced by
NeuroD6 is KIF5B, a kinesin motor protein involved in
mitochondrial transport.
Mitochondria and neurite outgrowth
During their differentiation, neurons extend neurites with
one becoming the axon and others becoming dendrites. This
polarity is important in the formation of functional neuronal
circuits.
During axogenesis, mitochondria congregate at the base of
the developing neurites that are destined to become axon
(Mattson and Partin, 1999). Once the axon forms and
accelerates its growth there is increased entry of mitochon-
dria into the new axon where they are concentrated at the
growth cone (Ruthel and Hollenbeck, 2003). Rather strikingly,
depletion of mitochondria at or before the stage of
axogenesis, under conditions where cellular ATP levels are
maintained using pyruvate and uridine as energy sources,
prevents axon formation (Mattson and Partin, 1999).
Furthermore, in dorsal root ganglion cells isolated from
neonatal rats, the mitochondria become reorganized to form
clusters in the axonal hillock of regenerating axons (Dedov
et al., 2000). These studies suggest that mitochondria play an
important role in neural polarization and axonal outgrowth
regulation.
The mechanisms by which mitochondria influence the
establishment of neuronal polarity remain to be established.
It was reported that the cytoplasmic free Ca
2+ concentration
Figure 1 Examples of methods for evaluating mitochondrial morphology, subcellular localization and functional status
(a) Each panel shows a single live embryonic rat hippocampal neuron at a different stage of development in culture (1, 5 and 14
days). Mitochondria in the neurons were stained with the fluorescent probe MitoTracker Red. Note that the immature neuron has
elaborated short processes, and that the vast majority of mitochondria are clustered in a perinuclear location. At 5 days in culture the
neuron exhibits longer neurites that contain multiple mitochondria, and perinuclear mitochondria remain abundant. Mitochondrial
numbers have increased, indicating that biogenesis has occurred. At 14 days in culture the neuron has elaborated an extensive
neuritic network with each neurite containing multiple mitochondria. Relative numbers of mitochondria in a perinuclear location are
reduced. (b) Example of the results of an experiment in which oxygen consumption, mitochondrial membrane potential and
cytoplasmic Ca
2+ levels were monitored in a single cultured embryonic rat hippocampal neuron before and during exposure to the
excitatory neurotransmitter glutamate. In response to glutamate receptor activation, oxygen consumption increased and then slowly
returned towards baseline levels, intracellular Ca
2+ levels rose rapidly and remained elevated, whereas mitochondrial membrane
potential declined progressively. Adapted from Gleichmann et al. (2009).
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245is lower surrounding the mitochondria at the base of the
developing axon in cultured embryonic rat hippocampal
neurons, and that exposure of the neurons to a calcium
ionophore (which increases the cytoplasmic Ca
2+ concentra-
tion throughout the cell) prevents axon formation (Mattson
and Partin, 1999). One possible explanation is that mito-
chondria act as a calcium buffering organelle to reduce the
Ca
2+ concentration at the base of the presumptive axon,
thereby promoting polymerization of microtubules and the
rapid growth and differentiation of the axon (Figures 2 and 3).
In addition to playing critical roles in neural polarization
and axonal outgrowth regulation, mitochondria may also be
required for normal dendrite development, maintenance and
plasticity. Studying the correlation between mitochondrial
energy status and mitochondrial membrane potential, Overly
et al. (1996) found that mitochondria in dendrites are
metabolically more active than those in the axons, although
the reason for this differential mitochondrial activity is
unknown. Recent studies provide experimental evidence
that mitochondria are important in regulating dendrite
development, maintenance and plasticity. Disruption of
mitochondrial protein translation in Drosophila olfactory
projection neurons preferentially reduces dendritic arbor-
ization, while axon morphology is relatively unaltered
(Chihara et al., 2007). Dendritic mitochondria also have
essential roles in dendritic spine morphogenesis and
plasticity.
Mechanisms by which mitochondria move within neurites
are beginning to be understood; their movement is affected
by energy-dependent transport along microtubules.
Mitochondrial transport can occur bidirectionally; micro-
tubule plus end-directed kinesin moves mitochondria in the
anterograde direction, whereas minus end-directed dynein
motors move mitochondria retrogradely (Hollenbeck and
Saxton, 2005; Zinsmaier et al., 2009; Pathak et al., 2010;
Figure 2). Measurements of the membrane potential of
individual mitochondria in the growing axons of chick
sensory neurons using the dye TMRM (tetramethylrhodamine
methyl ester) revealed no major differences among mito-
chondria along the length of the axon, and no differences in
Figure 2 Molecular machinery that actively moves mitochondria to and fro within axons
A major mechanism by which mitochondria are transported in either anterograde or retrograde directions in axons involves their
energy (ATP)-dependent movement along microtubules. ATP-dependent ‘motor’ proteins interact with the microtubules to generate
the force that moves the mitochondria in anterograde (kinesin) or retrograde (dynein) directions respectively. Several APs (adaptor
proteins) mediate the interaction of mitochondria with motor proteins, including APs that interact with kinesin (Milton, syntabulin
and the Rho GTPase Miro) and APs that associate with dynein (dynactin). In addition, in synaptic terminals and growth cones,
microtubules may be moved by myosin-mediated interactions with actin filaments. Myosin V can drive short-range movements along
F-actin, as well as modulate long-range transport by pulling mitochondria away from microtubules by facilitating anchorage of
mitochondria to F-actin by unknown actin–mitochondrion crosslinkers. Adapted from Mattson et al. (2008).
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dria (Verburg and Hollenbeck, 2008). However, the membrane
potential of mitochondria in the lamellipodia of growth cones
is significantly greater than the membrane potential of
mitochondria in the axon shaft. In another study that
employed the mitochondrial membrane potential-sensing dye
JC-1 to image mitochondria in growing axons of cultured
chick sensory neurons, it was found that most of the
mitochondria with a high potential were transported towards
the growth cone, whereas most mitochondria with a low
potential were transported towards the cell body (Miller and
Sheetz, 2004).
Using beads coupled with signals for axon outgrowth [NGF
(nerve growth factor)] or guidance (semaphoring 3A), it was
shown that both of these signals cause an increase in the mem-
brane potential of mitochondria immediately adjacent to the site
of the beads (Verburg and Hollenbeck, 2008). Additional data in
the latter study provided evidence that PI3K (phosphoinositide
3-kinase) and MAPK (mitogen-activated protein kinase) mediated
the effects of NGF and semaphorin 3A on mitochondrial
potential. Quantitative analyses of motility show that the
accumulation of axonal mitochondria near a focus of NGF
stimulation is due to increasedm o v e m e n ti n t ob e a dr e g i o n s
followed by inhibition of movement out of these regions and that
anterograde movement and retrograde movement are differenti-
ally affected. In axons made devoid of F-actin by latrunculin B
treatment, bidirectional transporto fm i t o c h o n d r i ac o n t i n u e s ,b u t
they can no longer accumulate in the region of NGF stimulation.
Additional experiments provided evidence that the regulation of
mitochondrial movement by NGF signalling involves increased
transport to the sites of stimulation in combination with
retention of the mitochondria by interactions with the actin
cytoskeleton (Chada and Hollenbeck, 2004).
Although most of the ATP production by mitochondria
occurs in the ETC (electron transport chain), mitochondrial
glycogenesis may enable or regulate physiological processes
in neurons, including neurite outgrowth. It is clear that
neuronal cells can survive without a functioning mitochon-
drial ETC, as demonstrated in cultured cells in which
mitochondria are depleted of their ATP and provided lactate
and pyruvate as energy substrates (Miller et al., 1996; Hyun et
al., 2007). One example comes from studies in which the
activity of hexokinase was manipulated in growing neurons;
hexokinase is an enzyme that plays a pivotal role early in the
Figure 3 The landscape of mitochondrial involvement in the plasticity of neuronal structure and information processing
Increasing evidence suggests that mitochondria play active roles in regulating the outgrowth of axons and dendrites, synaptogenesis
and morphological and functional responses to synaptic activity. Mitochondria in presynaptic terminals (1) provide the energy for the
maintenance and restoration of membrane potential, and may modulate neurotransmitter packaging and release. Mitochondria in
postsynaptic spines (2) and dendritic shafts (3) may enable/regulate both structural and functional responses of these compartments
to synaptic activity. Mitochondria in the cell body (4) provide the energy required for numerous biochemical processes, and may also
serve as signalling platforms involved in information transfer within the neuron. Mitochondria in axons (5) provide the energy
necessary for the transport of various proteins and organelles from the axon terminal to the cell body and vice versa.
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247glycolytic pathway in which glucose is metabolized to
generate ATP. When hexokinase is selectively inhibited using
a hexokinase-binding peptide, the ability of NGF to stimulate
neurite outgrowth in cultured adult sensory neurons is
impaired (Wang et al., 2008a).
Mitochondria and synaptic plasticity
The behaviour and functional properties of mitochondria
differ in axons and dendrites. For example, twice as many
mitochondria are motile in the axons compared with the
dendrites of cultured hippocampal neurons, and there is a
greater proportion of highly charged, more metabolically
active mitochondria in dendrites than in axons (Overly et al.,
1996). Both presynaptic axon terminals and postsynaptic
dendrites experience considerable metabolic and oxidative
stress as a result of activation of membrane voltage- and
ligand-gated Ca
2+ channels (Bezprozvanny and Mattson,
2008). Mitochondrial functions in synaptic plasticity have
been mostly studied at glutamatergic synapses, which are the
most abundant type of excitatory synapse in the central
nervous system. Activation of AMPA (a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid), NMDA (N-methyl-D-
aspartate) and metabotropic glutamate receptors results in
Ca
2+ influx through plasma membrane voltage-dependent
channels and NMDA receptor channels, and Ca
2+ release from
the endoplasmic reticulum (Toresson and Grant, 2005). The
mitochondria are essential components in synaptic transmis-
sion, since they are a major source of energy (ATP and NAD
+)
required for maintenance and restoration of ion gradients;
mitochondria are also intimately involved in the regulation of
Ca
2+ homoeostasis and Ca
2+ signalling (Duchen, 2000;
Nicholls and Budd, 2000; Toescu 2000). Presynaptic terminals
typically contain several mitochondria (Sheehan et al., 1997),
indicating that the local need for ATP and Ca
2+ handling is
great in this compartment. In response to neuronal
stimulation, synaptic mitochondria redistribute and enhance
their activity (Miller and Sheetz, 2004).
Mitochondria in dendrites are located mainly in the
dendritic shafts and are occasionally found associated with
spines (Cameron et al., 1991; Popov et al., 2005). The dendritic
distribution of mitochondria is regulated by neuronal activity
and mitochondrial fission/fusion proteins Drp1 and OPA1. Li
et al. (2004) showed that the number of dendritic spines with
mitochondria increases when the dendritic spines are actively
growing (embryonic rat hippocampal neurons 11–14 days in
culture), or when the neurons are subjected to repeated
depolarization with KCl (Li et al., 2004). Overexpressing a
dominant-negative form of Drp1 (A38K) reduces the number
of dendritic mitochondria and decreases the number of
synapses, whereas overexpressing wild-type Drp or treating
cells with creatine increases the number and/or activity
of dendritic mitochondria and nearly doubles the number of
synapses. Therefore mitochondria are important in dendritic
spine morphogenesis and plasticity.
Changes in mitochondria have been associated with LTP
(long-term potentiation) of synaptic transmission, a key event
in the learning and memory process (Williams et al., 1998;
Calabresi et al., 2001; Li et al., 2010). On the presynaptic side
there is evidence that the protein syntaphilin is a negative
regulator of mitochondrial motility in axons where it may
modulate mitochondria-mediated Ca
2+ signalling at presynap-
tic terminals (Kang et al., 2008). Kinesin-mediated transport of
mitochondria to presynaptic terminals was demonstrated to be
important for synaptic transmission as demonstrated in studies
oftheeffectsofMilton-deficientphotoreceptorsinDrosophila
(Stowers et al., 2002). The GTPase dMiro is also required for
axonal transport of mitochondria to Drosophila synapses (Guo
et al., 2005). Further work will be required to establish specific
and essential roles for mitochondrial recruitment to synapses
in LTP and other forms of synaptic plasticity.
While changes in the location of mitochondria within
axons and dendrites may play roles in synaptic plasticity, even
more rapid functional changes in mitochondria are increas-
ingly implicated. These changes may include mitochondrial
Ca
2+ uptake or release, the production of superoxide and
other ROS, and the release of proteins and other factors.
Post-tetanic potentiation, a form of plasticity that arises from
a persistent presynaptic Ca
2+ elevation after tetanic stimu-
lation, is blocked by inhibitors of mitochondrial Ca
2+ uptake
and release (Tang and Zucker, 1997). Chemical blockade of
mitochondrial permeability transition pores results in a
reduction in mitochondrial superoxide production (Wang
et al., 2008b) and an increase of basal synaptic transmission
and impaired synaptic plasticity (Levy et al., 2003). Other
findings suggest that presynaptic mitochondria play a role in
the maintenance of synaptic transmission by sequestering
Ca
2+ and thereby accelerating recovery from synaptic
transmission during periods of moderate to high synaptic
activity (Billups and Forsythe, 2002). Neurons in Drosophila
Drp1 mutants exhibit synapses devoid of mitochondria and
elevations in resting cytoplasmic Ca
2+ levels at neuromuscular
junctions (Verstreken et al., 2005). Basal synaptic transmission
is largely normal in Drp1 mutant flies, but during intense
stimulation mutants fail to maintain normal neurotransmis-
sion. Although exo- and endo-cytosis are normal in the
mutants, the ability to mobilize reserve pool vesicles is
impaired as the result of reduced ATP availability. Moreover,
age-related cognitive impairment in rats, and presumably the
synaptic plasticity subserving learning and memory, is
associated with structural abnormalities in mitochondria
and oxidation of RNA and DNA (Liu et al., 2002).
Emerging findings suggest roles for mitochondria as
mediators of at least some of the effects of glutamate and
BDNF on synaptic plasticity. An increasing number of
signalling functions for mitochondria are being discovered.
For example, glutamate receptor-mediated patterned syn-
aptic activity, such as occurs during stimulus train-induced
bursting, results in slow and prolonged changes in mitochon-
drial potential that exhibit both temporal and spatial
correlations with the intensity of the electrical activity
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membrane potential involve glutamate receptor-mediated
Ca
2+ influx. Synaptic activation of glutamate receptors
may also affect mitochondrial bioenergetics independently
of Ca
2+ influx as suggested by studies of stimulus-evoked
changes in NAD(P)H fluorescence at CA1 synapses in
hippocampal slices (Shuttleworth et al., 2003). Several
neurotrophic factors have been shown to modify synaptic
plasticity including BDNF, which plays a pivotal role in
hippocampus-dependent learning and memory (Lu et al.,
2009). BDNF promotes synaptic plasticity, in part, by
enhancing mitochondrial energy production because it
increases glucose utilization in cultured cortical neurons in
response to enhanced energy demand (Burkhalter et al.,
2003) and increases mitochondrial respiratory coupling at
Complex I (Markham et al., 2004). Consistent with this
possibility, BDNF expression and signalling is increased in
response to environmental factors such as exercise, cognitive
stimulation and dietary energy restriction that increase
cellular energy demand (Mattson et al., 2004).
Many questions remain unanswered concerning the roles
of mitochondria in synaptic plasticity. Are mitochondria in
presynaptic terminals phenotypically different from those
in dendrites? If and how does synaptic activity affect
mitochondrial function and motility? This could be deter-
mined by combining manipulations of specific signalling
components (glutamate receptors, Ca
2+-dependent and other
kinases, cyclic nucleotides, nitric oxide etc.) with high-
resolution imaging-based measurements of mitochondrial
motility and functional status (membrane potential, ROS and
Ca
2+ levels etc.). Behavioural and electrophysiological evalu-
ation of synaptic plasticity in mice with a conditional
knockdown of proteins with specific roles in mitochondrial
motility (Drp1, Fis1, Mfn and OPA) and function [components
of the mitochondrial ETC (electron transport chain), PTP
(protein tyrosine phosphatase), Ca
2+ handling systems, for
example] should help establish the roles of these proteins in
synaptic plasticity.
Mitochondrial biogenesis and neuroplasticity
Mitochondrial biogenesis is defined simply as the growth and
division of mitochondria. The human mitochondrial genome
contains 37 genes that encode 13 polypeptides, 22 tRNAs and
two rRNAs. All 13 polypeptides are subunits of electron
transport protein complexes in the inner membrane of
mitochondria. The vast majority of mitochondrial proteins
(,1000 proteins) are encoded by nuclear genes and include
proteins involved in controlling mitochondrial membrane
potential and ion fluxes, ATP production, and fission and
fusion. These nuclear DNA-encoded mitochondrial proteins
are imported into mitochondria, wherein they are sorted to
their sites of action (Figure 4). In addition, the growth of
mitochondria requires the synthesis of lipid bilayers of the
inner and outer mitochondrial membranes. Mitochondrial
DNA replication and mitochondrial fission and fusion
mechanisms must also be co-ordinated.
PGC1a (peroxisome-proliferator-activated receptor c co-
activator 1a) is a master regulator of mitochondrial
biogenesis (Figure 4). PGC1a is expressed at high levels in
mitochondria-rich cells with high energy demands, including
cardiac myocytes, skeletal-muscle cells and neurons
(Andersson and Scarpulla, 2001). It is a transcriptional co-
activator that lacks DNA-binding activity; instead it interacts
with and co-activates numerous transcription factors,
including nuclear receptors such as PPARc (peroxisome-
proliferator-activated receptor c), PPARa, oestrogen, thyroid
hormone and retinoid receptors, and other nuclear transcrip-
tion factors such as Nrf1 (nuclear respiratory factor 1). Nrf1
can activate the expression of mitochondrial target genes,
including the mitochondrial transcription factor (TFAM), a factor
critical for the initiation of mitochondrial DNA transcription and
replication. Nrf1 can further regulate the transcription of
nuclear genes encoding respiratory complex subunits and other
mitochondrial proteins.
An interesting aspect of mitochondrial biogenesis is that it
is influenced by dietary energy intake and expenditure. CR
(caloric restriction) and exercise stimulate mitochondrial
biogenesis in muscle and nerve cells by a PGC1a-mediated
mechanism (Puigserver et al., 1998; Yoon et al., 2001; Baar
et al., 2002; Lin et al., 2004; Norrbom et al., 2004; Nisoli et al.,
2005; Lo ´pez-Lluch et al., 2006). As described above, PGC1a
activates several transcription factors involved in the
regulation of mitochondrial biogenesis, lipid metabolism
and antioxidant response. PGC-la protein is very abundant
in neural progenitor cells and newly generated neurons in the
embryonic and early postnatal brain, suggesting a role for
PGC-la in the dynamic processes of neuroplasticity occurring
during this time period (Cowell et al., 2007). PGC1a-knockout
mice exhibit behavioral abnormalities and progressive cellular
vacuolization in various brain regions (Lin et al., 2004). Both
CR and exercise can stimulate adult neurogenesis and
enhance synaptic plasticity, which may enhance cognitive
function and the ability of the brain to resist aging (Ingram
et al., 1987; Pitsikas and Algeri, 1992; van Praag et al., 1999;
Eckles-Smith et al., 2000; Kempermann et al., 2000; Mattson
et al., 2003). It is conceivable that CR can enhance neural
plasticity during aging by maintaining PGC-1a-and mito-
chondrial turnover, as has been described in muscle cells of
animals maintained on CR (Hepple et al., 2006). CR can
enhance mitochondrial bioenergetics in neurons by increas-
ing cellular NAD
+ levels and increasing the activity of the
NAD
+-dependent histone deacetylase sirtuin-1 (Liu et al.,
2008). Mild mitochondrial uncoupling and CR exert hormetic
effects by stimulating bioenergetics in neurons, thereby
increasing tolerance of neurons to metabolic stress and
facilitating plasticity.
Several signalling molecules known to regulate neural
plasticity also modify mitochondrial biogenesis; examples
include nitric oxide, oestrogen, and growth factors, including
BDNF, EGF (epidermal growth factor) and bFGF (basic
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249fibroblast growth factor; Barsoum et al., 2006; Gutsaeva
et al., 2008; Klinge, 2008; Hebert et al., 2009; Renton et al.,
2010). Oestrogen, BDNF and nitric oxide each play critical
roles in modulating neurogenesis, hippocampal synaptic
plasticity and learning and memory (Cheng et al., 2003; Foy
et al., 2008; Hojo et al., 2008; Nikonenko et al., 2008; Brinton,
2009; Harooni et al., 2009; Minichiello, 2009; Vincent, 2009).
Thus there are several prominent signalling pathways that
stimulate mitochondrial biogenesis and energy metabolism,
while simultaneously regulating neuroplasticity. However, in
most cases the data linking mitochondrial biogenesis to
neuronal plasticity are associational in nature, and cause–
effect relationships remain to be established. It will be of
considerable interest to selectively inhibit mitochondrial
biogenesis using molecular genetic approaches that target
PGC-1a to establish roles for mitochondrial biogenesis in
experimental models of neuroplasticity.
Inherited neurodegenerative disorders provide
clues to the functions of mitochondria in
neuroplasticity
PD (Parkinson’s disease) is characterized by the progressive
degeneration of dopaminergic and noradrenergic neurons
that control motor and autonomic nervous system function
respectively (Halliday et al., 1990). Mitochondrial dysfunction
is believed to be an early and pivotal event in PD, because (i)
the activities of enzymes involved in mitochondrial energy
production are reduced early in the disease process (Schulz
and Beal, 1994); (ii) toxins that selectively inhibit mitochon-
drial Complex I can induce PD-like pathology and symptoms
in rodents, monkeys and humans (Greenamyre et al., 1999);
and (iii) some cases of inherited PD result from mutations
in genes encoding proteins involved in mitochondrial
physiology (Nuytemans et al., 2010). Recessively inherited
Figure 4 Mechanisms that regulate the growth and function of mitochondria
The vast majority of mitochondrial proteins are encoded by nuclear genes, whereas only 13 proteins that are all components of the
ETC are encoded by mitochondrial genes. Proteins are imported into mitochondria by translocases of the outer membrane (TOM) and
inner membrane (TIM) in a mitochondrial membrane potential-dependent manner. Mitochondrial DNA transcription is mediated by
an RNA polymerase, the transcription factor A (TFAM), TFB1M or TFB2M for transcription initiation, and mTERE for transcription
termination. Neurons contain particularly high levels of PGC1a, apparently because of their high energy utilization. PGC1a is a
transcriptional co-activator that interacts with various transcription factors, including the nuclear receptors PPARc, PPARa,
oestrogen, thyroid hormone and retinoid receptors and Nrf1/2. Nrf1/2 induces the transcription of nuclear genes that encode ETC
proteins, TFAM and proteins critical for mitochondrial biogenesis. Environmental factors (exercise, energy restriction and cold
temperature, for example) activate signalling pathways involving neurotransmitters, neurotrophic factors and nitric oxide (for
example), and intracellular cascades involving Ca
2+, CaMKII (Ca
2+/calmodulin-dependent protein kinase II), the phosphatase
calcineurin, and the transcription factor CREB (cAMP-response-element-binding protein). In this manner, PGC1a is activated and
mitochondrial biogenesis is stimulated. Modified from Mattson et al. (2008).
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and Pink1, compromise mitochondrial biogenesis and function
(Figure 5). Parkin mutations result in impaired mitochondrial
Complex I activity and abnormalities in mitochondrial
structure and fusion (Mortiboys et al., 2008; Park et al.,
2009). Studies of Parkin-deficient neurons suggest that this E3
ubiquitin ligase plays a role in synaptic plasticity, possibly by
suppressing neurotransmitter release. Studies of nigrostriatal
neurons in Parkin-null mice suggest that Parkin is a negative
regulator of dopamine release (Goldberg et al., 2003).
Knockdown of endogenous Parkin in cultured hippocampal
neurons enhances glutamatergic transmission and increases
neuronal vulnerability to synaptic excitotoxicity (Helton et al.,
2008). DJ-1, which localizes to mitochondria in neurons (Zhang
et al., 2005), plays an essential role in long-term decrease of
synaptic transmission (Wang et al., 2008c), suggesting that
impaired synaptic plasticity plays an early role in the
pathogenesis of PD.
Further evidence that perturbed mitochondrial function is
sufficient to cause synaptic dysfunction and PD comes from
studies of PINK1 [PTEN (phosphatase and tensin homologue
deleted on chromosome 10)-induced kinase 1; Figure 5].
PINK1 deficiency or PD-causing PINK1 mutations impair
mitochondrial Complex I activity, resulting in mitochondrial
membrane depolarization and increased vulnerability to stress
(Morais et al., 2009). An early functional abnormality in
PINK1 mutant animals is impaired neurotransmitter release
from presynaptic terminals, a problem that can be corrected
by increasing cellular ATP levels (Morais et al., 2009).
Mutations in LRRK2 (leucine-rich repeat kinase 2) are
responsible for some cases of autosomal dominantly inherited
PD; LRRK2 associates with the mitochondrial outer membrane
and interacts with Parkin (Mata et al., 2006). LRRK2 has been
shown to modify the vulnerability of cells to mitochondrial
dysfunction, with PD mutant forms of LRRK2 promoting
mitochondrial dysfunction (Saha et al., 2009). Primary
cultured neurons derived from LRRK2 G2019S mutant
transgenic mice exhibit increased growth cone size and
reduced neurite outgrowth characterized by increased levels
of F-actin in the growth cones (Parisiadou et al., 2009),
suggesting an adverse gain-of-function effect of this LRRK2
mutation on neuronal plasticity. The evidence that multiple
genetic aberrancies cause PD by adversely affecting mito-
chondrial function and biogenesis suggests that the earliest
impairments of synaptic plasticity in this disease are the
result of mitochondrial abnormalities.
Some cases of AD (Alzheimer’s disease) are inherited in an
autosomal dominant manner as the result of mutations in
APP (amyloid precursor protein) or presenilin-1 (Mattson,
2004). Both APP and presenilin-1 are believed to play roles in
developmental and synaptic plasticity, and mutations in these
proteins have been reported to alter neurogenesis and
synaptic plasticity (Mattson, 1997). There is evidence that
the secreted form of APP generated by a-secretase cleavage
of APP enhances neurogenesis (Caille ´ et al., 2004) and
synaptic plasticity (Ishida et al., 1997). On the other hand, the
Ab (amyloid b-peptide) generated by b- and c-secretases can
impair neurogenesis (Haughey et al., 2002a, 2002b) and
synaptic plasticity (Chapman et al., 1999). Inasmuch as Ab
impairs mitochondrial function (Keller et al., 1998), there may
be a role for perturbed mitochondrial function in the adverse
effects of Ab on neural plasticity (Mattson et al., 1998),
although this remains to be established. In the case of
presenilin-1 there is a well-established mechanism by which
this protease regulates neurogenesis and adult neuroplasti-
city, namely presenilin-1 cleaves Notch to generate the NICD
(Notch intracellular domain), which then translocates to the
nucleus where it modulates the transcription of genes
involved in regulating neuroplasticity (Lathia et al., 2008).
Studies of Drosophila (Presente et al., 2004) and mice with
reduced Notch levels (Costa et al., 2003; Wang et al., 2004)
have demonstrated a critical role for Notch signalling in
synaptic plasticity and learning and memory. Presenilin-1
mutations that cause AD have been reported to impair
neurogenesis by perturbing Notch signalling (Veeraraghavalu
et al., 2010) and may also impair some forms of synaptic
plasticity (Auffret et al., 2010). Whether there is a role for
mitochondrial changes in the actions of Notch signalling on
neuroplasticity is unknown; however, it has been reported
that Notch signalling interacts with mitochondrial remod-
elling proteins (Perumalsamy et al., 2010), suggesting a
potential role for mitochondria in some biological effects of
Notch signalling.
Perturbed mitochondrial behaviours are also implicated in
the impaired synaptic plasticity, and motor and cognitive
deficits, in HD (Huntington’s disease). Polyglutamine repeat
expansions in the huntingtin protein cause HD, and several
lines of transgenic mice expressing such mutant huntingtin
proteins develop neurodegenerative changes in the striatum
and cerebral cortex, and motor and cognitive deficits similar
to HD. In one HD mouse model, layer II/III neurons in
the perirhinal cortex exhibit impaired LTP, which is
associated with nuclear accumulation of mutant huntingtin
and membrane depolarization (e.g. Cummings et al., 2006).
LTP at hippocampal synapses is impaired in HD mutant
mice (Usdin et al., 1999). Accumulating data point to
mitochondrial abnormalities as an early consequence of
mutant huntingtin that contributes to impaired neural
plasticity. Early events may include defective mitochondrial
calcium handling, ATP production and trafficking (Oliveira,
2010). Mutant huntingtin can impair transcription of
nuclear genome-encoded mitochondrial proteins, and may
also inhibit biogenesis and subcellular trafficking of
mitochondria.
The kinds of findings described in the preceding
paragraphs suggest that impaired neural plasticity occurs
in the earliest stages of neurodegenerative disorders,
and abnormalities in mitochondrial function, motility and
biogenesis may contribute to the early dysfunction of
neurons. The complexity of the architecture and signalling
processes in neuronal circuits provides the basis for
sophisticated behaviours including higher cognitive functions
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251(language, decision making, creativity etc.). However, this
cellular complexity increases the demands on the networks
and the potential for ‘weak links’ (neurons that are
particularly prone to faltering under adverse conditions such
as traumatic injury, stroke, diabetes and aging). The
development of therapeutic interventions aimed at enhancing
mitochondrial function and plasticity in vulnerable neurons is
an active area for preclinical and translational research for
many neurological disorders (Mattson et al., 2008). Indeed,
preclinical studies have demonstrated beneficial effects of
creatine (a chemical that facilitates regeneration of ATP in
mitochondria) in animal models of neurodegenerative dis-
orders (Adhihetty and Beal, 2008) and traumatic brain injury
(Sullivan et al., 2000). Additional mitochondria-focused
treatments that show promise in preclinical studies include
Mn-SOD (manganese superoxide dismutase) mimetics (Brazier
et al., 2008), mitochondrial uncoupling agents (Liu et al.,
2006; Pandya et al., 2007) and coenzyme Q10 (Chaturvedi and
Beal, 2008).
FUTURE DIRECTIONS
While considerable data have accrued regarding the local-
ization of mitochondria at subcellular sites where plasticity
occurs and the movement and fission or fusion of
Figure 5 Influence of neurodegenerative disease-related proteins proteins on mitochondrial function and plasticity
The AD APP is a single-pass transmembrane protein that includes the 42-amino-acid Ab (red). Ab is liberated upon sequential
cleavages of APP by b-secretase (bs) at the N-terminus of Ab and c-secretase at the C-terminus of Ab; the latter cleavage is
executed by presenilin-1 (PS1; an integral membrane protein that is the enzymatic component of the c-secretase protein complex).
An alternative cleavage of APP within the Ab sequence by the a-secretase enzyme produces a secreted form of APP that is believed
to play important roles in developmental and synaptic plasticity, and neuron survival. Whereas Ab is normally cleared from the brain, in
AD it self-aggregates to form oligomers and during this process ROS are generated and propagated to the cell membrane, resulting
in lipid peroxidation, impairment of membrane ion (Na
+ and Ca
2+) transporters and excessive Ca
2+ influx through glutamate
receptor (NMDA) channels. In addition to increasing Ab production, mutations in PS1 that cause AD perturb endoplasmic reticulum
(ER) Ca
2+, resulting in excessive Ca
2+ release. Mitochondrial Ca
2+ homoeostasis and energy production may be impaired in neurons
in AD as the result of cellular Ca
2+ overload and increased oxidative stress possibly involving direct actions of Ab on mitochondrial
membranes. The pathological scenario just described involves perturbations in signalling pathways normally involved in adaptive
neuroplasticity, with glutamate signalling being a well-established example. Glutamate-induced Ca
2+ is normally transient with the
Ca
2+ activating kinases such as CaMK and MAPK. The kinases in turn activate transcription factors (TF) that induce the expression
of nuclear genes that encode proteins involved in effecting adaptive morphological and functional responses of the neurons. CREB
is one such synaptic activity-responsive transcription factor that induces the expression of BDNF, a protein critically involved in
synaptic plasticity and neuronal survival. The successive discoveries of genes-linked inherited forms of PD placed mitochondrial
alterations at centre stage in the pathogenesis of PD, and also revealed novel proteins that regulate mitochondrial functional and
structural plasticity. A feature of all cases of PD is the intracellular accumulation of a-synuclein, apparently as the result of impaired
degradation by the proteasome. Parkin (an E3 ubiquitin ligase), DJ-1, PINK1 and LRRK2 have each been shown to modify mitochondrial
function (ATP and ROS production), and some findings suggest that Parkin, PINK1 and LRRK2 also influence mitochondrial fission and
fusion. PINK1 and DJ-1 may suppress intramitochondrial oxidative stress, whereas Parkin and DJ-1 inhibit the opening of
mitochondrial permeability transition pores, thereby protecting neurons against apoptotic cell death that can be triggered by release
of cytochrome c (CytC) from the mitochondria. Finally, in HD, mutant huntingtin (Htt) self-aggregates and impairs CREB-mediated
transcription of BDNF, thereby compromising a pathway critical for neuronal plasticity and survival. See the text of this paper and the
following references for additional information and discussion (Mattson, 1997; Mattson, 2004; Mattson et al., 2004; Cattaneo et al.,
2005; Cookson, 2005; Nuytemans et al., 2010).
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questions remain just correlative and/or unanswered con-
cerning the roles of mitochondria in neuroplasticity. To
establish roles of mitochondrial energy production, redox and
Ca
2+ signalling, motility and biogenesis in neuroplasticity,
several approaches may be employed: (i) use RNA interference
technology to knock down the expression or function of
proteins involved in specific mitochondrial events such as
fission/fusion, biogenesis or targeted inhibition of mitochon-
drial mobility and functions selectively in subcellular
compartments such as synapse, dendrites or axons. This could
be accomplished in both cell culture and in vivo models. (ii)
Perform time lapse analysis of mitochondrial movements
within subcellular compartments in response to physiological
stimuli, and in combination with selective ablation and/or
artificial movement of mitochondria may establish the
requirement of mitochondria for specific physiological events
(neurite outgrowth and dendritic remodelling). (iii)
Behavioural and electrophysiological evaluation of synaptic
plasticity in mice with conditional knockout of proteins with
specific roles in mitochondrial motility (Drp1, Mfn1/2 and
OPA1) and biogenesis (PGC1a and TFAM). (iv) Utilization of
novel fluorescent probes for mitochondrial superoxide, in
combination with superoxide scavengers (Mn-SOD mimetics,
for example). As such technologies are becoming widely
available, it is very likely that there will be a rapid
acceleration of our knowledge of how, where and why
mitochondria respond to and regulate neural plasticity and
how abnormalities in such mechanisms contribute to the
pathogenesis of neurological disorders.
REFERENCES
Adhihetty PJ, Beal MF (2008) Creatine and its potential therapeutic value for
targeting cellular energy impairment in neurodegenerative diseases.
Neuromolecular Med 10:275–290.
Andersson U, Scarpulla RC (2001) Pgc-1-related coactivator, a novel, serum-
induciblecoactivator of nuclearrespiratory factor 1-dependent transcription
in mammalian cells. Mol Cell Biol 21, 3738–3749.
Auffret A, Gautheron V, Mattson MP, Mariani J, Rovira C (2010) Progressive
age-related impairment of the late long-term potentiation in Alzheimer’s
disease presenilin-1 mutant knock-in mice. J Alzheimers Dis 19:1021–
1033.
Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy
JO (2002) Adaptations of skeletal muscle to exercise: rapid increase in
the transcriptional coactivator PGC-1. FASEB J 16:1879–1886.
Barres BA. The mystery and magic of glia: a perspective on their roles in
health and disease. Neuron 2008; 60:430–440.
Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gra ¨ber S, Kovacs I,
Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ,
Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E (2006) Nitric oxide-
induced mitochondrial fission is regulated by dynamin-related GTPases in
neurons. EMBO J 25:3900–3911.
Baxter KK, Uittenbogaard M, Yoon J, Chiaramello A (2009) The neurogenic basic
helix–loop–helix transcription factor neuroD6 concomitantly increases
mitochondrial mass and regulates cytoskeletal organization in the early
stages of neuronal differentiation. ASN NEURO 1(4):art:e00016doi:10.1042/
AN20090036
Berman SB, Pineda FJ, Hardwick JM (2008) Mitochondrial fission and fusion
dynamics: the long and short of it. Cell Death Differ 15:1147–1152.
Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the
pathogenesis of Alzheimer’s disease. Trends Neurosci 31:454–463.
Billups B, Forsythe ID (2002) Presynaptic mitochondrial calcium sequestration
influences transmission at mammalian central synapses. J Neurosci
22:5840–5847.
Bindokas VP, Lee CC, Colmers WF, Miller RJ (1998) Changes in mitochondrial
function resulting from synaptic activity in the rat hippocampal slice.
J Neurosci 18:4570–4587.
Bramham CR (2008) Local proteinsynthesis, actin dynamics, and LTP consolidation.
Curr Opin Neurobiol 18:524–531.
Brazier MW, Doctrow SR, Masters CL, Collins SJ (2008) A manganese-
superoxide dismutase/catalase mimetic extends survival in a mouse
model of human prion disease. Free Radical Biol Med 45:184–192.
Brinton RD (2009) Estrogen-induced plasticity from cells to circuits:
predictions for cognitive function. Trends Pharmacol Sci 30:212–222.
Burkhalter J, Fiumelli H, Allaman I, Chatton JY, Martin JL.(2003) Brain-derived
neurotrophic factor stimulates energy metabolism in developing cortical
neurons. J Neurosci 23:8212–8220.
Caille ´ I, Allinquant B, Dupont E, Bouillot C, Langer A, Mu ¨ller U, Prochiantz A
(2004) Soluble form of amyloid precursor protein regulates proliferation
of progenitors in the adult subventricular zone. Development 131:2173–
2181.
Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P,
Hipskind RA, Borrelli E, Bernardi G (2001) Inhibition of mitochondrial
complex II induces a long-term potentiation of NMDA-mediated synaptic
excitation in the striatum requiring endogenous dopamine. J Neurosci
21:5110–5120.
Cameron HA, Kaliszewski CK, Greer CA (1991) Organization of mitochondria
in olfactory bulb granule cell dendritic spines. Synapse 8:107–118.
Cane KN, Anderson CR (2009) Generating diversity: Mechanisms regulating
the differentiation of autonomic neuron phenotypes. Auton Neurosci
151:17–29.
Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an
alternative approach to Huntington’s disease. Nat Rev Neurosci 6:919–
930.
Chada SR, Hollenbeck PJ (2004) Nerve growth factor signaling regulates
motility and docking of axonal mitochondria. Curr Biol 14:1272–1276.
Chan SL, Liu D, Kyriazis GA, Bagsiyao P, Ouyang X, Mattson MP (2006)
Mitochondrial uncoupling protein-4 regulates calcium homeostasis and
sensitivity to store depletion-induced apoptosis in neural cells. J Biol
Chem 281:37391–37403.
Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry
M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK (1999)
Impaired synaptic plasticity and learning in aged amyloid precursor
protein transgenic mice. Nat Neurosci 2:271–276.
Chaturvedi RK, Beal MF (2008) Mitochondrial approaches for neuroprotec-
tion. Ann NY Acad Sci 1147:395–412.
Cheng A, Wang S, Cai J, Rao MS, Mattson MP (2003) Nitric oxide acts in a
positive feedback loop with BDNF to regulate neural progenitor cell
proliferation and differentiation in the mammalian brain. Dev Biol
258:319–333.
Chihara T, Luginbuhl D, Luo L (2007) Cytoplasmic and mitochondrial protein
translation in axonal and dendritic terminal arborization. Nat Neurosci
10:828–837.
Cookson MR (2005) The biochemistry of Parkinson’s disease. Annu Rev
Biochem 74:29–52.
Costa RM, Honjo T, Silva AJ (2003) Learning and memory deficits in Notch
mutant mice. Curr Biol 13:1348–1354.
Cowell RM, Blake KR, Russell JW (2007) Localization of the transcriptional
coactivator PGC-1a to GABAergic neurons during maturation of the rat
brain. J Comp Neurol 502:1–18.
Cummings DM, Milnerwood AJ, Dalle ´rac GM, Waights V, Brown JY, Vatsavayai
SC, Hirst MC, Murphy KP (2006) Aberrant cortical synaptic plasticity and
dopaminergic dysfunction in a mouse model of Huntington’s disease.
Hum Mol Genet 15:2856–2868.
Dedov VN, Armati PJ, Roufogalis BD (2000) Three-dimensional organisation of
mitochondrial clusters in regenerating dorsal root ganglion (DRG)
neurons from neonatal rats: evidence for mobile mitochondrial pools.
J Peripher Nerv Syst 5(1):3–10.
Detmer SA, Chan DC (2007) Functions and dysfunctions of mitochondrial
dynamics. Nat Rev Mol Cell Biol 8:870–879.
Duchen MR (2000) Mitochondria and Ca
2+ in cell physiology and
pathophysiology. Cell Calcium 28:339–348.
Eckles-Smith K, Clayton D, Bickford P, Browning MD (2000) Caloric restriction
prevents age-related deficits in LTP and in NMDA receptor expression.
Mol Brain Res 78:154–162.
E 2010 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
253Foy MR, Baudry M, Diaz Brinton R, Thompson RF (2008) Estrogen and
hippocampal plasticity in rodent models. J Alzheimers Dis 15:589–603.
Ge S, Sailor KA, Ming GL, Song H (2008) Synaptic integration and plasticity of
new neurons in the adult hippocampus. J Physiol 586:3759–3765.
Gleichmann M, Collis LP, Smith PJ, Mattson MP (2009) Simultaneous single
neuron recording of O2 consumption, [Ca
2+]i and mitochondrial membrane
potential in glutamate toxicity. J Neurochem 109:644–655.
Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A,
Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL,
Chesselet MF, Maidment NT, Levine MS, Shen J (2003) Parkin-deficient
mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
J Biol Chem 278:43628–43635.
Gottmann K, Mittmann T, Lessmann V (2009) BDNF signaling in the
formation, maturation and plasticity of glutamatergic and GABAergic
synapses. Exp Brain Res 199:203–234.
Greenamyre JT, MacKenzie G, Peng TI, Stephans SE (1999) Mitochondrial
dysfunction in Parkinson’s disease. Biochem Soc Symp 66:85–97.
Greer PL, Greenberg ME (2008) From synapse to nucleus: calcium-dependent
gene transcription in the control of synapse development and function.
Neuron 59:846–860.
Guo X, Macleod GT, Wellington A, Hu F, Panchumarthi S, Schoenfield M,
Marin L, Charlton MP, Atwood HL, Zinsmaier KE (2005) The GTPase dMiro
is required for axonal transport of mitochondria to Drosophila synapses.
Neuron 47:379–393.
Gutsaeva DR, Carraway MS, Suliman HB, Demchenko IT, Shitara H, Yonekawa
H, Piantadosi CA (2008) Transient hypoxia stimulates mitochondrial
biogenesis in brain subcortex by a neuronal nitric oxide synthase-
dependent mechanism. J Neurosci 28:2015–2024.
Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, Blessing
WW, Geffen LB (1990) Neuropathology of immunohistochemically
identified brainstem neurons in Parkinson’s disease. Ann Neurol
27:373–385.
Hamby ME, Coskun V, Sun YE (2008) Transcriptional regulation of neuronal
differentiation: the epigenetic layer of complexity. Biochim Biophys Acta
1779:432–437.
Harooni HE, Naghdi N, Sepehri H, Rohani AH (2009) The role of hippocampal
nitric oxide (NO) on learning and immediate, short- and long-term
memory retrieval in inhibitory avoidance task in male adult rats. Behav
Brain Res 201:166–172.
Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP (2002a)
Disruption of neurogenesis by amyloid beta-peptide, and perturbed
neural progenitor cell homeostasis, in models of Alzheimer’s disease.
J Neurochem 83:1509–1524.
Haughey NJ, Liu D, Nath A, Borchard AC, Mattson MP (2002b) Disruption of
neurogenesis in the subventricular zone of adult mice, and in human
cortical neuronal precursor cells in culture, by amyloid beta-peptide:
implications for the pathogenesis of Alzheimer’s disease. Neuromolecular
Med 1:125–135.
Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission
and neurovascular coupling. Physiol Rev 86:1009–1031.
Hebert TL, Wu X, Yu G, Goh BC, Halvorsen YD, Wang Z, Moro C, Gimble JM
(2009) Culture effects of epidermal growth factor (EGF) and basic
fibroblast growth factor (bFGF) on cryopreserved human adipose-derived
stromal/stem cell proliferation and adipogenesis. J Tissue Eng Regen Med
3:553–561.
Helton TD, Otsuka T, Lee MC, Mu Y, Ehlers MD (2008) Pruning and loss of
excitatory synapses by the parkin ubiquitin ligase. Proc Natl Acad Sci USA
105:19492–19497.
Hepple RT, Baker DJ, McConkey M, Murynka T, Norris R (2006) Caloric
restriction protects mitochondrial function with aging in skeletal and
cardiac muscles. Rejuvenation Res 9:219–222.
Hildebrandt H, Mu ¨hlenhoff M, Weinhold B, Gerardy-Schahn R (2007)
Dissecting polysialic acid and NCAM functions in brain development.
J Neurochem 103:S56–S64.
Hojo Y, Murakami G, Mukai H, Higo S, Hatanaka Y, Ogiue-Ikeda M, Ishii H,
Kimoto T, Kawato S (2008) Estrogen synthesis in the brain–role in
synaptic plasticity and memory. Mol Cell Endocrinol 290:31–43.
Hollenbeck PJ, Saxton WM (2005) The axonal transport of mitochondria.
J Cell Sci 118:5411–5419.
Hyun DH, Hunt ND, Emerson SS, Hernandez JO, Mattson MP, de Cabo R
(2007) Up-regulation of plasma membrane-associated redox activities in
neuronal cells lacking functional mitochondria. J Neurochem 100:1364–
1374.
Ingram DK, Weindruch R, Spangler EL, Freeman JR, Walford RL (1987) Dietary
restriction benefits learning and motor performance of aged mice.
J Gerontol 42:78–81.
Ishida A, Furukawa K, Keller JN, Mattson MP (1997) Secreted form of beta-
amyloid precursor protein shifts the frequency dependency for induction
of LTD, and enhances LTP in hippocampal slices. Neuroreport 8:2133–
2137.
Kang JS, Tian JH, Pan PY, Zald P, Li C, Deng C, Sheng ZH (2008) Docking of
axonal mitochondria by syntaphilin controls their mobility and affects
short-term facilitation. Cell 132:137–148.
Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A, Santel A,
Fuller M, Smith CL, Youle RJ (2002) Spatial and temporal association of
Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis.
J Cell Biol 159:931–938.
Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner
SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial
manganese superoxide dismutase prevents neural apoptosis and reduces
ischemic brain injury: suppression of peroxynitrite production, lipid
peroxidation, and mitochondrial dysfunction. J Neurosci 18:687–697.
Kempermann G, van Praag H, Gage FH (2000) Activity-dependent regulation
of neuronal plasticity and self repair. Prog Brain Res 127:35–48.
Kempermann G, Wiskott L, Gage FH (2004) Functional significance of adult
neurogenesis. Curr Opin Neurobiol 14:186–191.
Kitamura T, Saitoh Y, Takashima N, Murayama A, Niibori Y, Ageta H, Sekiguchi
M, Sugiyama H, Inokuchi K (2009) Adult neurogenesis modulates the
hippocampus-dependent period of associative fear memory. Cell
139:814–827.
Klinge CM (2008) Estrogenic control of mitochondrial function and
biogenesis. J Cell Biochem 105:1342–1351.
Kondoh H, Lleonart ME, Nakashima Y, Yokode M, Tanaka M, Bernard D, Gil J,
Beach D (2007) A high glycolytic flux supports the proliferative potential
of murine embryonic stem cells. Antioxid Redox Signal 9:293–299.
Koshiba T, Detmer SA, Kaiser JT, Chen H, McCaffery JM, Chan DC (2004)
Structural basis of mitochondrial tethering by mitofusin complexes.
Science 305:858–862.
Lathia JD, Mattson MP, Cheng A (2008) Notch: from neural development to
neurological disorders. J Neurochem 107:1471–1481.
Levy M, Faas GC, Saggau P, Craigen WJ, Sweatt JD (2003) Mitochondrial
regulation of synaptic plasticity in the hippocampus. J Biol Chem
278:17727–17734.
Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic
mitochondria in the morphogenesis and plasticity of spines and synapses.
Cell 119:873–887.
Li Z, Jo J, Jia JM, Lo SC, Whitcomb DJ, Jiao S, Cho K, Sheng M (2010) Caspase-
3 activation via mitochondria is required for long-term depression and
AMPA receptor internalization. Cell 141:859–871.
Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Ja ¨ger
S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper
MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB,
Krainc D, Spiegelman BM (2004) Defects in adaptive energy metabolism
with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119:121–
135.
Liesa M, Palacı ´n M, Zorzano A (2009) Mitochondrial dynamics in mammalian
health and disease. Physiol Rev 89:799–845.
Lipsky RH, Marini AM (2007) Brain-derived neurotrophic factor in neuronal
survival and behavior-related plasticity. Ann NY Acad Sci 1122:130–143.
Liu D, Chan SL, de Souza-Pinto NC, Slevin JR, Wersto RP, Zhan M, Mustafa K,
de Cabo R, Mattson MP (2006) Mitochondrial UCP4 mediates an
adaptive shift in energy metabolism and increases the resistance of
neurons to metabolic and oxidative stress. Neuromolecular Med 8:389–
414.
Liu D, Pitta M, Mattson MP (2008) Preventing NAD
+ depletion protects
neurons against excitotoxicity: bioenergetic effects of mild mitochondrial
uncoupling and caloric restriction. Ann NY Acad Sci 1147:275–282.
Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW,
Ames BN (2002) Memory loss in old rats is associated with brain
mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding
acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci USA
99:2356–2361.
Loers G, Schachner M (2007) Recognition molecules and neural repair.
J Neurochem 101:865–882.
Lo ´pez-Lluch G, Hunt N, Jones B, Zhu M, Jamieson H, Hilmer S, Cascajo MV,
Allard J, Ingram DK, Navas P, de Cabo R (2006) Calorie restriction induces
mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci
USA 103:1768–1773.
Lu B, Wang KH, Nose A (2009) Molecular mechanisms underlying neural
circuit formation. Curr Opin Neurobiol 19:162–167.
A Cheng and others
254 E 2010 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Macaskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J,
Fransson A, Aspenstrom P, Attwell D, Kittler JT (2009) Miro1 is a calcium
sensor for glutamate receptor-dependent localization of mitochondria at
synapses. Neuron 61:541–555.
Markham JA, Greenough WT (2004) Experience-driven brain plasticity:
beyond the synapse. Neuron Glia Biol 1:351–363.
Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA (2006) LRRK2 in
Parkinson’s disease: protein domains and functional insights. Trends
Neurosci 29:286–293.
Mattson MP (1988) Neurotransmitters in the regulation of neuronal
cytoarchitecture. Brain Res 472:179–212.
Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its
soluble and fibrillogenic derivatives. Physiol Rev 77:1081–1132.
Mattson MP, Guthrie PB, Hayes BC, Kater SB (1989) Roles for mitotic history
in the generation and degeneration of hippocampal neuroarchitecture.
J Neurosci 9:1223–1232.
Mattson MP, Partin J, Begley JG (1998) Amyloid beta-peptide induces
apoptosis-related events in synapses and dendrites. Brain Res 807:167–
176.
Mattson MP, Partin J (1999) Evidence for mitochondrial control of neuronal
polarity. J Neurosci Res 56:8–20.
Mattson MP, Liu D (2003) Mitochondrial potassium channels and uncoupling
proteins in synaptic plasticity and neuronal cell death. Biochem Biophys
Res Commun 304:539–549.
Mattson MP, Duan W, Guo Z (2003) Meal size and frequency affect neuronal
plasticity and vulnerability to disease: cellular and molecular mechan-
isms. J Neurochem 84:417–431.
Mattson MP (2004) Pathways towards and away from Alzheimer’s disease.
Nature 430:631–639.
Mattson MP, Maudsley S, Martin B (2004) BDNF and 5-HT: a dynamic duo in
age-related neuronal plasticity and neurodegenerative disorders. Trends
Neurosci 27:589–594.
Mattson MP (2008) Glutamate and neurotrophic factors in neuronal plasticity
and disease. Ann NY Acad Sci 1144:97–112.
Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity
and neurological disorders. Neuron 60:748–766.
Miller KE, Sheetz MP (2004) Axonal mitochondrial transport and potential are
correlated. J Cell Sci 117:2791–2804.
Miller SW, Trimmer PA, Parker Jr WD, Davis RE (1996) Creation and
characterization of mitochondrial DNA-depleted cell lines with ‘neur-
onal-like’ properties. J Neurochem 67:1897–1907.
Minichiello L (2009) TrkB signalling pathways in LTP and learning. Nat Rev
Neurosci 10:850–860.
Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M, Haddad
D, Frezza C, Mandemakers W, Vogt-Weisenhorn D, Van Coster R, Wurst
W, Scorrano L, De Strooper B (2009) Parkinson’s disease mutations in
PINK1 result in decreased Complex I activity and deficient synaptic
function. EMBO Mol Med 1:99–111.
Morrison SJ, Csete M, Groves AK, Melega W, Wold B, Anderson DJ (2000)
Culture in reduced levels of oxygen promotes clonogenic sympathoa-
drenal differentiation by isolated neural crest stem cells. J Neurosci
20:7370–7376.
Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S,
Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O (2008)
Mitochondrial function and morphology are impaired in parkin-mutant
fibroblasts. Ann Neurol 64:555–565.
Newpher TM, Ehlers MD (2008) Glutamate receptor dynamics in dendritic
microdomains. Neuron 58:472–497.
Nicholls DG, Budd SL (2000) Mitochondria and neuronal survival. Physiol Rev
80:315–60.
Nikonenko I, Boda B, Steen S, Knott G, Welker E, Muller D (2008) PSD-95
promotes synaptogenesis and multiinnervated spine formation through
nitric oxide signaling. J Cell Biol 183:1115–1127.
Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio
A, Cantoni O, Clementi E, Moncada S, Carruba MO (2005) Calorie
restriction promotes mitochondrial biogenesis by inducing the expression
of eNOS. Science 310:314–317.
Norrbom J, Sundberg CJ, Ameln H, Kraus WE, Jansson E, Gustafsson T (2004)
PGC-1alpha mRNA expression is influenced by metabolic perturbation in
exercising human skeletal muscle. J Appl Physiol 96:189–194.
Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology
of Parkinson disease associated with mutations in the SNCA, PARK2,
PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat
31:763–780.
Oliveira JM (2010) Nature and cause of mitochondrial dysfunction in
Huntington’s disease: focusing on huntingtin and the striatum. J Neurochem
114, 1–12.
Overly CC, Rieff HI, Hollenbeck PJ (1996) Organelle motility and metabolism
in axons vs dendrites of cultured hippocampal neurons. J Cell Sci
109:971–980.
Pak CW, Flynn KC, Bamburg JR (2008) Actin-binding proteins take the reins in
growth cones. Nat Rev Neurosci 9:136–147.
Pandya JD, Pauly JR, Nukala VN, Sebastian AH, Day KM, Korde AS, Maragos
WF, Hall ED, Sullivan PG. Post-injury administration of mitochondrial
uncouplers increases tissue sparing and improves behavioral
outcome following traumatic brain injury in rodents. J Neurotrauma
24:798–811.
Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, Long CX, Lobbestael E, Baekelandt V,
Taymans JM, Sun L, Cai H (2009) Phosphorylation of ezrin/radixin/moesin
proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in
neuronal morphogenesis. J Neurosci 29:13971–13980.
Park J, Lee G, Chung J (2009) The PINK1-Parkin pathway is involved in the
regulation of mitochondrial remodeling process. Biochem Biophys Res
Commun 378:518–523.
Pathak D, Sepp KJ, Hollenbeck PJ (2010) Evidence that myosin activity
opposes microtubule-based axonal transport of mitochondria. J Neurosci
30(26):8984–8992.
Perumalsamy LR, Nagala M, Sarin A (2010) Notch-activated signaling cascade
interacts with mitochondrial remodeling proteins to regulate cell survival.
Proc Natl Acad Sci USA 107:6882–6887.
Pitsikas N, Algeri S (1992) Deterioration of spatial and nonspatial reference
and working memory in aged rats: protective effect of life-long calorie
restriction. Neurobiol Aging 13:369–373.
Popov V, Medvedev NI, Davies HA, Stewart MG (2005) Mitochondria form a
filamentous reticular network in hippocampal dendrites but are present
as discrete bodies in axons: a three-dimensional ultrastructural study.
J Comp Neurol 492:50–65.
Presente A, Boyles RS, Serway CN, de Belle JS, Andres AJ (2004) Notch is
required for long-term memory in Drosophila. Proc Natl Acad Sci USA
101:1764–1768.
Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J (2010) The senescence-
related mitochondrial/oxidative stress pathway is repressed in human
induced pluripotent stem cells. Stem Cells 28:721–733.
Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM (1998) A
cold-inducible coactivator of nuclear receptors linked to adaptive
thermogenesis. Cell 92:829–839.
Renton JP, Xu N, Clark JJ, Hansen MR (2010) Interaction of neurotrophin
signaling with Bcl-2 localized to the mitochondria and endoplasmic
reticulum on spiral ganglion neuron survival and neurite growth.
J Neurosci Res 88:2239–2251.
Rodrigues CA, Diogo MM, da Silva CL, Cabral JM (2010) Hypoxia enhances
proliferation of mouse embryonic stem cell-derived neural stem cells.
Biotechnol Bioeng 106:260–270.
Ruthel G, Hollenbeck PJ (2003) Response of mitochondrial traffic to axon
determination and differential branch growth. J Neurosci 23:8618–8624.
Saha S, Guillily MD, Ferree A, Lanceta J, Chan D, Ghosh J, Hsu CH, Segal L,
Raghavan K, Matsumoto K, Hisamoto N, Kuwahara T, Iwatsubo T, Moore
L, Goldstein L, Cookson M, Wolozin B (2009) LRRK2 modulates
vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.
J Neurosci 29:9210–9218.
Santilli G, Lamorte G, Carlessi L, Ferrari D, Rota Nodari L, Binda E, Delia D,
Vescovi AL, De Filippis L (2010) Mild hypoxia enhances proliferation and
multipotency of human neural stem cells. PLoS One 51:e8575.
Schulz JB, Beal MF (1994) Mitochondrial dysfunction in movement disorders.
Curr Opin Neurol 7:333–339.
Shah MM, Hammond RS, Hoffman DA (2010). Dendritic ion channel
trafficking and plasticity. Trends Neurosci 33:307–316.
Shaw JM, Nunnari J (2002) Mitochondrial dynamics and division in budding
yeast. Trends Cell Biol 12:178–184.
Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB
(1997) Calcium homeostasis and reactive oxygen species production in
cells transformed by mitochondria from individuals with sporadic
Alzheimer’s disease. J Neurosci 17:4612–4622.
Shepherd JD, Huganir RL (2007) The cell biology of synaptic plasticity: AMPA
receptor trafficking. Annu Rev Cell Dev Biol 23:613–643.
Shuttleworth CW, Brennan AM, Connor JA (2003) NAD(P)H fluorescence
imaging of postsynaptic neuronal activation in murine hippocampal
slices. J Neurosci 23:3196–208.
E 2010 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
255Smorodchenko A, Rupprecht A, Sarilova I, Ninnemann O, Bra ¨uer AU, Franke K,
Schumacher S, Techritz S, Nitsch R, Schuelke M, Pohl EE (2009)
Comparative analysis of uncoupling protein 4 distribution in various
tissues under physiological conditions and during development. Biochim
Biophys Acta 1788:2309–2319.
Sotelo C, Palay SL (1968) The fine structure of the lateral vestibular nucleus
in the rat: I. Neurons and neuroglial cells. J Cell Biol 36:151–179.
Sotelo C, Dusart I (2009) Intrinsic versus extrinsic determinants during the
development of Purkinje cell dendrites. Neuroscience 162:589–600.
Stowe DF, Camara AK (2009) Mitochondrial reactive oxygen species
production in excitable cells: modulators of mitochondrial and cell
function. Antioxid Redox Signalling 11:1373–1414.
Stowers RS, Megeath LJ, Go ´rska-Andrzejak J, Meinertzhagen IA, Schwarz TL
(2002) Axonal transport of mitochondria to synapses depends on Milton,
a novel Drosophila protein. Neuron 36:1063–1077.
Sullivan PG, Geiger JD, Mattson MP, Scheff SW (2000) Dietary supplement
creatine protects against traumatic brain injury. Ann Neurol 48:723–729.
Tai HC, Schuman EM (2008) Ubiquitin, the proteasome and protein
degradation in neuronal function and dysfunction. Nat Rev Neurosci
9:826–838.
Tang Y, Zucker RS (1997) Mitochondrial involvement in post-tetanic
potentiation of synaptic transmission. Neuron 18(3):483–491.
Toescu EC (2000) Mitochondria and Ca
2+ signaling. J Cell Mol Med 4:164–
175.
Toresson H, Grant SG (2005) Dynamic distribution of endoplasmic reticulum
in hippocampal neuron dendritic spines. Eur J Neurosci 22:1793–1798.
Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic
plasticity in mice carrying the Huntington’s disease mutation. Hum Mol
Genet 8:839–846.
van Praag H, Christie BR, Sejnowski TJ, Gage FH (1999) Running enhances
neurogenesis, learning, and long-term potentiation in mice. Proc Natl
Acad Sci USA 96:13427–13431.
Vayssie `re JL, Cordeau-Lossouarn L, Larcher JC, Basseville M, Gros F, Croizat B
(1992) Participation of the mitochondrial genome in the differentiation
of neuroblastoma cells. In Vitro Cell Dev Biol 28A:763–772.
Veeraraghavalu K, Choi SH, Zhang X, Sisodia SS (2010) Presenilin 1 mutants
impair the self-renewal and differentiation of adult murine subventri-
cular zone-neuronal progenitors via cell-autonomous mechanisms
involving notch signaling. J Neurosci 30:6903–6915.
Verburg J, Hollenbeck PJ (2008) Mitochondrial membrane potential in
axons increases with local nerve growth factor or semaphorin signaling.
J Neurosci 28:8306–8315.
Verstreken P, Ly CV, Venken KJ, Koh TW, Zhou Y, Bellen HJ (2005) Synaptic
mitochondria are critical for mobilization of reserve pool vesicles at
Drosophila neuromuscular junctions. Neuron 47:365–378.
Vincent JL (2009) Learning and memory: while you rest, your brain keeps
working. Curr Biol 19:R484–R486.
Voccoli V, Colombaioni L (2009) Mitochondrial remodeling in differentiating
neuroblasts. Brain Res 1252:15–29.
Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, Mattson MP,
Furukawa K (2004) Involvement of Notch signaling in hippocampal
synaptic plasticity. Proc Natl Acad Sci USA 101:9458–9462.
Wang Z, Gardiner NJ, Fernyhough P (2008a) Blockade of hexokinase activity
and binding to mitochondria inhibits neurite outgrowth in cultured adult
rat sensory neurons. Neurosci Lett 434:6–11.
Wang W, Fang H, Groom L, Cheng A, Zhang W, Liu J, Wang X, Li K, Han P,
Zheng M, Yin J, Wang W, Mattson MP, Kao JP, Lakatta EG, Sheu SS,
Ouyang K, Chen J, Dirksen RT, Cheng H (2008b) Superoxide flashes in
single mitochondria. Cell 134:279–290.
Wang Y, Chandran JS, Cai H, Mattson MP (2008c) DJ-1 is essential for long-
term depression at hippocampal CA1 synapses. Neuromol Med 10:40–45.
Williams JM, Thompson VL, Mason-Parker SE, Abraham WC, Tate WP (1998)
Synaptic activity-dependent modulation of mitochondrial gene express-
ion in the rat hippocampus. Mol Brain Res 60:50–56.
Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford
J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM (2001) Control of
hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
Nature 413:131–138.
Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, Marupudi NI, Torp R,
Torgner IA, Ottersen OP, Dawson TM, Dawson VL (2005) Mitochondrial
localization of the Parkinson’s disease related protein DJ-1: implications
for pathogenesis. Hum Mol Genet 14:2063–2073.
Zhang P, Pazin MJ, Schwartz CM, Becker KG, Wersto RP, Dilley CM, Mattson
MP (2008) Nontelomeric TRF2-REST interaction modulates neuronal gene
silencing and fate of tumor and stem cells. Curr Biol 18:1489–1494.
Zinsmaier KE, Babic M, Russo GJ (2009) Mitochondrial transport dynamics in
axons and dendrites. Results Probl Cell Differ 48:107–139.
Received 16 June 2010/6 August 2010; accepted 13 August 2010
Published as Immediate Publication 13 August 2010, doi 10.1042/AN20100019
A Cheng and others
256 E 2010 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.